| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01119
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME SULT1A1 |
[1] |
| Formaldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde up-regulates the expression of DME SULT1A1 |
[2] |
| Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Cyanotoxin |
| DME Modulation |
Cylindrospermopsin inhibits the expression of DME SULT1A1 |
[3] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the expression of DME SULT1A1 |
[4] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME SULT1A1 |
[2] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME SULT1A1 |
[4], [5] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Glycidamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01009
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Glycidamide up-regulates the expression of DME SULT1A1 |
[6] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Aloe-emodin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01191
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Aloe-emodin inhibits the drug-metabolizing activity of DME SULT1A1 |
[7] |
| Chrysophanic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01528
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Chrysophanic acid inhibits the drug-metabolizing activity of DME SULT1A1 |
[7] |
| Gallic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01309
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Gallic acid induces the drug-metabolizing activity of DME SULT1A1 |
[8] |
| Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Jinfukang |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Traditional Medicine |
| DME Modulation |
Jinfukang up-regulates the expression of DME SULT1A1 |
[9] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the drug-metabolizing activity of DME SULT1A1 |
[10] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide up-regulates the expression of DME SULT1A1 |
[11] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME SULT1A1 |
[12], [13] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME SULT1A1 |
[14] |
| Methotrexate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Methotrexate induces the drug-metabolizing activity of DME SULT1A1 |
[15], [16] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Butyric acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01230
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
Butyric acid up-regulates the expression of DME SULT1A1 |
[17] |
| Ethanol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ethanol inhibits the drug-metabolizing activity of DME SULT1A1 |
[18] |
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME SULT1A1 |
[19] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Trichostatin A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01492
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Trichostatin A up-regulates the expression of DME SULT1A1 |
[20] |
| Xanthohumol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00636
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Xanthohumol inhibits the drug-metabolizing activity of DME SULT1A1 |
[21] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Emodin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00692
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
Emodin inhibits the drug-metabolizing activity of DME SULT1A1 |
[7] |
| ICG-001 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 up-regulates the expression of DME SULT1A1 |
[22] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Phenylmercuric acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Phenylmercuric acetate up-regulates the expression of DME SULT1A1 |
[23] |
| Rhein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01455
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Rhein inhibits the drug-metabolizing activity of DME SULT1A1 |
[24] |
|
|
|
|
|
|